Study authors identified two congress abstracts and nine randomized controlled trials: eight of which were related to undifferentiated arthritis, and one which was related to very early RA. Early ...
Please provide your email address to receive an email when new articles are posted on . For the prevention of rheumatoid arthritis to become feasible, it may be necessary to intervene as soon as ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Rheumatoid arthritis prevention in patients at the subclinical or pre-clinical stage remains ...
Studies designed to shed light on the prediction of rheumatoid arthritis (RA) are showing substantial promise -- not only for RA but a host of other rheumatic diseases. Rheumatology care professionals ...
Philadelphia, June 10, 2019 - Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that leads to significant health issues as well as high treatment costs. In this themed issue of ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Ra Pharmaceuticals Presents Pre-Clinical Data for Zilucoplan XR at the 6 th Annual Peptides Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today presented pre-clinical data for an extended release (XR) formulation of zilucoplan at the 6 th Annual Peptides Congress, ...
As a chronic condition, rheumatoid arthritis (RA) can't be cured, so treatment focuses on managing the disease and controlling its progression. Although current treatments help control RA symptoms in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results